China Literature Limited disclosed that it repurchased 2.00 million ordinary shares on the Hong Kong Stock Exchange between 2 and 11 September 2026, all of which are designated for cancellation. The transactions occurred under the company’s general mandate approved on 2 June 2026.

Key details

• Outstanding share capital untouched (pre-cancellation): Issued shares remained at 1.014 billion as of 11 September 2026, identical to the opening balance on 10 September 2026. • Buyback volume and scale: 2.00 million shares, equivalent to approximately 0.20 % of the current issued share base, were repurchased but had not yet been cancelled by the reporting date. • Aggregate consideration: HKD 40.94 million, implying a volume-weighted average cost of about HKD 20.47 per share. • Daily activity: The company repurchased 200,000–400,000 shares on each trading day from 2 to 11 September, at average prices ranging between HKD 19.68 and HKD 21.44 per share. On 11 September alone, 200,000 shares were bought back at prices between HKD 19.46 and HKD 19.89, for HKD 3.94 million. • Mandate utilisation: To date, China Literature has bought back 15.65 million shares under the existing mandate, representing 1.53 % of the 1.02 billion shares outstanding when the mandate was granted. The company is authorised to repurchase up to 102.15 million shares. • Moratorium: In accordance with Hong Kong Listing Rules, China Literature is restricted from issuing new shares or selling any treasury shares until 11 October 2026.

Implications

The latest series of on-market buybacks underscores management’s ongoing capital-return strategy. While the repurchased shares have yet to be cancelled, their eventual removal would marginally reduce the share count and enhance earnings per share. Investors should monitor subsequent filings for confirmation of cancellation and any further utilisation of the remaining buyback mandate.